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Abstract: Secreted antimicrobial peptides (AMPs) are an important part of the human innate
immune system and prevent local and systemic infections by inhibiting bacterial growth in
a concentration-dependent manner. In the respiratory tract, the cationic peptide LL-37 is one
of the most abundant AMPs and capable of building pore complexes in usually negatively charged
bacterial membranes, leading to the destruction of bacteria. However, the adaptation mechanisms of
several pathogens to LL-37 are already described and are known to weaken the antimicrobial effect
of the AMP, for instance, by repulsion, export or degradation of the peptide. This study examines
proteome-wide changes in Streptococcus pneumoniae D39, the leading cause of bacterial pneumonia,
in response to physiological concentrations of LL-37 by high-resolution mass spectrometry. Our data
indicate that pneumococci may use some of the known adaptation mechanisms to reduce the effect
of LL-37 on their physiology, too. Additionally, several proteins seem to be involved in resistance
to AMPs which have not been related to this process before, such as the teichoic acid flippase TacF
(SPD_1128). Understanding colonization- and infection-relevant adaptations of the pneumococcus
to AMPs, especially LL-37, could finally uncover new drug targets to weaken the burden of this
widespread pathogen.
Keywords: Streptococcus pneumoniae; antimicrobial peptide; LL-37; adaptation; proteomics
1. Introduction
Infections of the lower respiratory tract, especially pneumonia, remain the third leading cause of
death and the deadliest communicable disease [1]. Among the causative agents of these diseases is the
Gram-positive bacteria Streptococcus pneumoniae, the leading cause of bacterial pneumonia [2]. Besides
that, S. pneumoniae is responsible for other serious diseases like meningitis and septicemia following
bacterial invasion into the bloodstream and milder, but even more frequent infections, of the middle
ear (otitis media) or sinuses (sinusitis) [3].
Today, two main approaches are used to fight pneumococcal disease. First, vaccination to
prevent initial infection, and second, treatment with classical antibiotics. However, the currently
available vaccines against S. pneumoniae are solely directed against capsule serotypes of selected strains,
and debate about the rapid replacement of vaccine-serotypes with non-vaccine-serotypes is rising [4].
On the other hand, the permanent risk for the development of antibiotic-resistant pneumococcal strains
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makes it necessary to develop new antimicrobial strategies to combat S. pneumoniae infections in the
future [5].
Interestingly, humans themselves produce endogenous antibiotics called antimicrobial peptides
(AMPs) to inhibit infections [6]. In general, antimicrobial peptides are small (12–50 amino acids)
amphipathic molecules that exhibit a net-positive charge under physiological conditions [7,8]. Specificity
for the bacterial membranes is mainly due to anionic charged phospholipids, in addition to negative
charges of LPS in Gram-negative, and teichoic acids in Gram-positive, bacteria. In contrast to that,
mammalian membranes predominantly consist of zwitterionic phospholipids. Likewise, the presence
of cholesterol reduces the activity of AMPs towards membranes [7,9–12].
The predominant human AMPs are histatins, defensins and a single, 37-amino acid long (4.5 kDa)
cathelicidin named LL-37 [13]. While histatins are a class of AMPs found in saliva and are thus just
indirectly involved in lung homeostasis [13], several defensins and cathelicidin LL-37 play an essential
role in lung innate immunity [14]. Actually, α-defensins are highly present in neutrophils, β-defensins
mainly in airway epithelia cells and LL-37 in neutrophils and airway epithelia cells [6,15]. Indeed,
LL-37 seems to be the most prominent AMP in bronchoalveolar fluid, with a concentration of up
to 25 µg/mL [16], and several studies revealed that LL-37 is clearly involved in defense of the lung
against bacterial infections [14]. The best-known effect of LL-37 on bacteria is the perforation of their
membranes via toroidal pore formation [7,17–19]. Furthermore, LL-37 interrupts the bacterial cell wall
synthesis and potentially interacts with pathogenic intracellular protein targets like chaperones [10,20].
Moreover, the disturbance of peptidoglycan synthesis [7] and neutralization of bacterial toxins other
than Gram-negative-derived LPS [10] seem plausible. Finally, LL-37 can act as a chemokine to attract
leukocytes to the side of infection. This process initiates a diverse immune response against pathogens
and elevates the local LL-37 concentration to an even higher level [21].
Considering these modes of action, the antimicrobial peptide LL-37 represents an important
stress factor for bacteria, and therefore molecular effectors evolved that reduce the damaging impact
of the AMP on the bacterial physiology [9]. Known adaptation mechanisms include the repulsion
of LL-37 by cell-surface adaptations, interception or the targeted binding of LL-37 by the release or
reconstruction of surface molecules, the export of LL-37 by ABC-transporters and the degradation
or modification of LL-37 [7,22]. The repulsion of LL-37 by cell surface adaptations inhibits the initial
interaction between the peptide and the bacterial membrane or cell wall. This is mainly accomplished
by modifications to the surface charge. The reduction in negative charges or the introduction of
positive charges to bacterial membranes and associated structures like teichoic acids and peptidoglycan
decreases the attraction of cationic LL-37 [23–25]. The interception or targeted binding of LL-37 is
thought to be mediated by the release of surface molecules like capsular polysaccharides, teichoic acids
and peptidoglycan or the possible restructuring of the peptidoglycan scaffold [16,26,27]. Potentially,
the effects of intracellular LL-37 can be counteracted by specific bacterial efflux pumps exporting these
peptides [28,29]. In fact, S. pneumoniae expresses more than 300 transporters. For a visual overview see:
http://www.membranetransport.org/transportDB2/index.html [30]. Lastly, the degradation of LL-37 by
proteases, or the hypothetical charge modification of the AMP, would decrease the interaction with the
bacterial cell surface. Indeed, this represents a common strategy, that is potentially involved in LL-37
resistance [31,32].
Although adaptations to LL-37 are already described for some bacteria, it remains to be elucidated
how S. pneumoniae, the leading cause of bacterial pneumonia, reacts to LL-37 stress on a functional
level. In this study, gel-free liquid chromatography-mass spectrometry (LC-MS)-based proteomics was
used to analyze the proteome of pneumococci under LL-37 stress compared to untreated pneumococci
for the first time.
As carriage of S. pneumoniae is a prerequisite for infection [3], understanding the interaction between
innate immune molecules, specifically AMPs, and pneumococci would give us more opportunities to
fight this widespread pathogen. In fact, enhancing the effect of existing antibiotics via the application
of antimicrobial peptides was shown and could be an interim solution to fight drug-resistant strains.
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Presumably, the membrane disruption effect of AMPs promotes access for classical antibiotics into
bacterial cells, and this would also explain the synergy between AMPs and antibiotics [7,13,33].
Moreover, resistance against classical antibiotics sensitizes bacteria for antimicrobial peptides [34].
On the other hand, attempts to block the bacterial resistance system to already existing AMPs in the
human body continue to be a promising medical approach [23].
2. Materials and Methods
For the present study, the following workflow was established by the optimization of numerous
parameters including cultivation, protein extraction, digestion, peptide fractionation, LC-MS/MS
methods and database search (Figure 1).
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2.1. Bacteria and Cultivation
The extensively characterized Streptococcus pneumoniae D39 strain (serotype 2, NCTC 7466) was
taken from cryo culture and incubated for 12 h on Columbia blood agar plates at 37 ◦C under 5% CO2
atmosphere. Bacteria were then transferred for pre-c ltivation to 40 mL modified RPMI 1640 media
(Thermo Fisher Scientific, Rockford, IL, USA) (further named chemically defined media = CDM) [35]
and the bacterial growth was photometrically obs rved while cultivating at 37 ◦C in a water bath
without agitation. When the culture r ached an optical density (OD600) of 0.5, cells were diluted in
40 mL of CDM to a starting OD600 of 0.07 to receive the main culture. Cultivation was performed under
the same parameters as before. After 2 h of bact rial growth, 2.5 µg/mL LL-37 acetate (Innovag n,
Lund, Sweden) was add d to the stress samples. For controls, an equivalent volume of distilled water
(100 µL) was added. Finally, pneumococci w re harvested by centrifugation (25 min, 10,000× g, 4 ◦C,
soft d celeration) directly before the addition of stress and after 1 nd 2 h of LL-37 treatment together
with the corresponding control samples. Bact rial pellets were fr zen at −80 ◦C until further pr cessing.
Experiments were perform d in six independe t biological replicates.
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2.2. Colony Forming Unit (CFU) Assay
Bacteria were grown, stressed and harvested as described before (Section 2.1) in three biological
replicates. Following that, cell pellets were diluted to an OD600 of 1 in 1 mL sterile phosphate-buffered
saline (PBS) [36] corresponding to about 109 bacteria. A total of 100 µL of further (1:100,000) diluted
samples were pipetted on blood agar plates. The plates were homogenously covered with bacterial
suspension using glass pearls. After the removal of pearls, the plates were incubated for 11 h at 37 ◦C
under 5% CO2 atmosphere and the colonies were counted.
2.3. LL-37 Sensitivity Testing
S. pneumoniae D39 wildtype (wt), as well as∆dltD and∆licD2 deletion mutants, were cultivated and
stressed as mentioned before (Section 2.1). For evaluating the sensitivity of pneumococci towards LL-37,
levels of reduction in optical density caused by the peptide were measured in triplicate experiments in
the three strains studied. Differences between mutant and wt inhibition were statistically analyzed
using one-tailed t-tests assuming unequal variance, p < 0.05.
2.4. Mutant Construction
The pneumococcal licD2 mutant in S. pneumoniae D39 was constructed by amplification of
a DNA fragment consisting of the S. pneumoniae D39 licD2 gene and ~500 bp up and downstream
flanking regions using polymerase chain reaction (PCR) with primer LicD2SphIfor (5´-GCGCGCGCAT
GCTATTGATA CTCGAAATAC AAAAACCTAT G-3´) and LicD2SacIrev (5´-GCGCGCGAGC
TCTGGTAAGA TTGGTGATGA CGATAAGG-3´). The purified PCR product was cloned into
plasmid pUC18 (Thermo Fisher Scientific, Rockford, IL, USA). The resulting plasmid was
used as a template for an inverse PCR using primer Invrev1130BamHI (5´-GCGCGCGGAT
CCCCTAATCC TCCAATTTAT AAGCG-3´) and Invfor1130SmaI (5´-GCGCGCCCCG GGTTGAGGGG
GATTATACAA ACTAC-3´). Afterwards, an ermB gene, amplified by PCR from vector pTP1 [37]
using primer InvrevBamHIErm (5´-GCGCGCGGAT CCACGGTTCG TGTTCGTGCT GACTTGC-3´)
and InforSmaIErm (5´-GCGCGCCCCG GGGTAGGCGC TAGGGACCTC TTTAGC-3´) was inserted.
The final recombinant plasmid was used to transform and mutagenize S. pneumoniae D39.
For the construction of S. pneumoniae D39∆dltD, a DNA fragment containing the dltD gene
and ~500 bp up and downstream of dltD was amplified by PCR using Primer DltDforXbaI
(5´-GCTCTAGACG AGTGGTCCAA TCGATCGCTT TAAGC-3´) and DltdrevSacI (5´-GCGAGCTCCC
AAGCGTTTGT CTCGATGTTC CCACATG-3´). The purified PCR fragment was cloned into the
pMiniT vector (NEB) and the resulting vector was used as a template for an inverse PCR with primer
InvKpnI (5´-GCGCTCTAGA GCGTTTAAGC ATTTTGTAGC TC-3´) and InvNcoI (5´-GCGCCCATGG
GATGGAGATG TCAAAGAATT TCAAT-3´). The ermB gene, amplified from plasmid pTP1 [37] using
primer ermforw (5´-GATGATGATG ATCCCGGGTA CCAAGCTTGA ATTCACGGTT CGTGTTCGTG
CTG-3´) and ermrevNcoI (5´-GCGCCCATGG CGTAGGCGCT AGGGACCTC-3´) was cloned into the
inverse PCR product. The final vector was used to transform and mutagenize S. pneumoniae D39.
2.5. Sample Preparation for LC-MS Measurements
2.5.1. Protein Extraction and Determination
Loss of hydrophobic proteins during protein extraction was minimized by resuspension of
pneumococcal pellets in 1 mL 50 mM triethylammonium bicarbonate (TEAB) lysis buffer (pH 7.55)
containing 5% SDS (wt/wt) and 8 M urea. Subsequently, the bacterial suspension was pipetted to cyro
tubes filled with 500 µL glass beads (diameter: 0.10 - 0.11 mm). Cells were disrupted by bead beating
(6 m/s, 4 × 30 s with 120 s breaks on ice) and subsequent sonication (1 × 60 s). In order to separate the
protein-containing supernatant from cell debris, a centrifugation step was performed (8 min, 13,000× g,
4 ◦C).
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Protein content was determined using BCA-assays (Pierce BCA Protein Assay Kit; Thermo Fisher
Scientific, Rockford, IL, USA) following the manufacturers protocol.
2.5.2. Protein Digestion
For tryptic digestion of 50 µg protein, S-trap spin columns (Protifi, Huntington, NY, USA)
were used in combination with the manufactures “ultra-high recovery protocol” available under
https://www.protifi.com/resources. Shortly, protein samples were reduced and alkylated and loaded
into the suspension traps. Then, the protein solution was acidified, and trypsin added (Promega,
Madison, WI, USA) and immediately washed several times. After the addition of further trypsin to the
matrix, the trap was incubated for 1 h at 47 ◦C, enabling protein digestion. Lastly, peptides were eluted
with acetonitrile and dried using a vacuum concentrator.
2.5.3. Peptide Fractionation
To increase the proteomic coverage, peptides were fractionated following the basic pH
reversed-phase peptide fractionation protocol (Thermo Fisher Scientific, Rockford, IL, USA) using
self-packed columns filled with 18 µg of Reprosil-Gold 300 C18, 5 µm material (Dr. Maisch,
Ammerbuch-Entringen, Germany). Basically, peptides were loaded into the column, washed and
eluted into eight different fractions using increasing concentrations of acetonitrile in a high-pH solution
(0.1% triethylamine). Afterwards, the fractions 1&5, 2&6, 3&7 and 4&8 were orthogonally combined
for optimal use of LC-MS analysis time according to the principles described elsewhere [38].
Finally, peptides were dried and suspended in 40 µL 0.5× iRTs in water with 0.1% acetic acid
(Biognosys, Schlieren, Switzerland) for LC-MS quality control purposes.
2.6. LC-MS Measurements
Samples were measured on an LTQ Orbitrap Velos mass spectrometer in combination with
an EASY nLC-1000 liquid chromatography system. First, 2 µL of the sample was loaded with 12 µL
buffer A (water with 0.1% acetic acid) on an in-house packed C18 column (ReproSil-Pur 120 C18-AQ,
3 µm material) of 20 cm length and 100 µm inner diameter. Then, a non-linear 180-min gradient
from 1% to 99% buffer B (acetonitrile with 0.1% acetic acid) was used for the elution of peptides with
a flowrate of 300 nl/min. The MS measurement was performed in data-dependent mode. The MS1
scans covered a mass range of 300–1700 m/z at a resolution of 30,000 (at 400 m/z) and the 20 most intense
precursors were selected and fragmented via collision-induced dissociation (CID) using a normalized
collision energy of 35. Ions with unknown charge or charge one were excluded from fragmentation.
Fragment ions were measured in the ion trap (MS2). Additionally, precursors were excluded for 20 s
after fragmentation for additional fragmentation.
2.7. Quality Control and Data Analysis
2.7.1. Quality Control
Data quality was monitored by adding synthetic iRT peptides (Biognosys, Schlieren, Switzerland)
to the samples, thereby checking for potential shifts in mass deviation or retention time. Additionally,
MaxQuant output files and RawMeat (VAST Scientific, Cambridge, MA, USA) were used to detect
unexpected changes in intensity, the number of obtained scans, the distribution of TopN or identification
rates. Finally, hierarchical clustering and a principle component analysis confirmed the quality of our
data, showing clustering of replicates, sample points and conditions (Figure S1). Only data passing the
quality checks were used in this study.
2.7.2. Protein Identification and Quantification
MaxQuant version 1.6.5.0 and its Andromeda search engine [39] was used for protein identification
and quantification with the following settings. Trypsin/P was selected as a protease that cleaves after
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lysine and arginine independent of following prolines. The maximal number of missed cleavages was set
to 2. Likewise, the minimal number of unique peptides per protein group was set to 2 to be considered as
identified. Oxidation (M) was considered as a variable and carbamidomethyl (C) as a fixed modification,
whereas the maximal number of modifications per peptide was 5. For quantification, solely unique
peptides were used. Databases loaded to MaxQuant were: the S. pneumoniae D39 proteome containing
1915 proteins obtained from Uniprot.org (Proteome ID: UP000001452, last modified November 9, 2018),
the MaxQuant contaminants file and sequences for human LL-37, yeast enolase and iRT peptides.
2.7.3. Data Evaluation
Data were analyzed using Perseus [40] version 1.6.5.0. Initially, the quantitative values were
transformed using the function: log2(x). Next, values were filtered based on the criteria: only identified
by site, reverse, potential contamination, identified in at least 5/6 biological replicates under at least 1/5
condition. Missing values were imputed from normal distribution using the Perseus standard settings.
For examination of differences between stress and control samples, Student’s t-tests were used (S0: 0,
side: both, use for truncation: p-value, threshold p-value: 0.01). Furthermore, a minimum fold change
of 1.5 was defined to extract the most prominent proteomic differences between the tested conditions,
which are expected to have an impact on physiology. Lastly, protein annotations were made using the
S. pneumoniae D39 proteome obtained from Uniprot.org (Proteome ID: UP000001452, last modified
November 9, 2018) supplemented with data obtained from PneumoBrowse [41], the subcellular
localization database PSORTdb 3.0 [42] and information on the two-component regulatory system
CiaHR [43].
2.8. Data Availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE [44] partner repository with the dataset
identifier PXD016511.
3. Results
To investigate the proteomic response of pneumococci towards LL-37, S. pneumoniae D39 was
stressed by the addition of 2.5 µg/mL LL-37 during the exponential growth phase (two hours after
the inoculation of main cultures) that was expected to be physiologically relevant. Furthermore,
pre-experiments showed a clear and concentration-dependent antibacterial effect of the peptide,
ranging from a profound inhibition of bacterial growth using 20 µg/mL of LL-37 to almost no inhibition
by adding 0.625 µg/mL peptide to pneumococcal cultures.
In our experiment, the application of stress reduced the maximal optical density (OD600) of
the cultures by about 20% (Figure 2A). Moreover, the viability of stressed cells was confirmed via
colony-forming unit (CFU) assays (Figure 2B). Five samples, 1× before the addition of LL-37, 2× after
1 h of stress (control, stress) and 2× after 2 h of stress (control, stress), were harvested in six biological
replicates and prepared for MS, as shown in Figure 1. This allowed us to link the significant reduction
in optical density of the stressed bacterial cultures to their proteomic state.
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Figure 2. (A) Effect of 2.5 µg/mL LL-37 on the growth of S. pneumoniae D39. The red arrow indicates
the application of the stress after two hours of cultivation. Error bars represent the standard deviation.
n = 6. (B) Colony-forming units (CFU) per ml OD600 = 1 bacterial suspension. Samples were taken
every hour after the addition of 2.5 µg/mL LL-37. Means are shown and error bars represent the
standard deviation. n = 3.
In total, 68% of the pneumococcal proteome (1293/1915 proteins) could be identified. Proteins
annotated to be cytoplasmic or cell-wall-bound could be identified as almost 80%. Additionally,
membrane proteins, extracellular proteins and proteins of unknown localization were covered to about
50%. Finally, the quantitative correlation between the data of biological replicates was at least 97.7%
(Figure 3, Figures S2–S6), demonstrating the high reproducibility of our experimental approach.
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Figure 3. Graphical representation of proteome coverage and correlation of replicates.
As the obtained dataset passed all executed quality control steps, Stude t’s t-tests were used for
the evaluati n of differenc s in the proteome of stressed a d unstre sed pneumococci consisting f
1118 pro eins after valu -filtering in Perseus. One hour after application of AMP stre s, 45 proteins
were significa tly chang d in abundanc (33 l ss abundant, 12 highe abu da t) and 2 h after st ess 78
prot ins (38 less abundant, 40 higher abundant) fulfille the strict t-test’s criteria to be considered a
changed (Figure 4). Furth rmore, many proteins that wer changed after 1h of stress wer lso foun
to be significant y change i abundance after 2h ho rs of stress in a similar manner.
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plots. Proteins with an increase in abundance after application of the stress are labeled in red and
proteins with a decrease in protein abundance in blue, respectively. # Student’s t-test (p-value= 0.01,
min. fold change = 1.5).
Subsequently, significantly changed proteins could be classified into functional groups:
transporters (29 proteins), proteins involved in gene regulation (11), a single protease (1), metabolic
proteins (12), cell surface modification proteins (7), virulence factors (7) and uncategorized proteins
(other (27) and unknown (11)). Hence, a total number of 105 proteins with a significantly changed
amount (43 lower in abundance, 62 higher abundant) could be identified after the addition of LL-37
(Figure 5, Table S1).
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Before in-depth analyses, the proteome data were compared to publicly available high-quality
genomics and gene regulation data for the pneumococcus [41,43] and a transcriptomics dataset for
pneumococci after LL-37 stress [45]. Briefly, proteins were considered for further analyzation if at least
two criteria were fulfilled. These include bacterial resistance candidates with significantly changed
abundances on proteome and transcriptome levels, proteins that were found to be changed at both
timepoints on proteome level (after 1h and 2h of stress), hits of several proteins of a single operon,
or if levels of a protein and its corresponding regulator were significantly altered after LL-37 stress
application. This resulted in a new, extensively examined dataset (Figure 6, Table S2).
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Basically, the abundance of many transporters, especially ABC-transporters, changed significantly
and often drastically after LL-37 exposure. Eight proteins annotated as transporters were increased
in abundance and eight proteins of this class decreased. Most prominent was the more than 8-fold
increase in the multidrug ABC transporter SPD_1525-26 after 2h of stress (7.5-fold after 1h of stress) and
the significant decrease in SPD_1527-28 sodium ABC exporter (down to 0.4-fold after 1h of stress and
0.3-fold after 2h of stress for SPD_1527). Likewise, the transcriptional regulator SPD_1524 (GntR) was
found in considerably higher abundance after LL-37 stress. Additionally, the sensor histidine kinase
CiaH and the response regulator CiaR increased after stress at both timepoints. Other proteins involved
in gene regulation with a moderately higher level after LL-37 treatment are BlpS (fold change (fc) of 1.8
at the second timepoint) and ComE (fc of 1.5 at the same sa ple point). Besides that, the heat-inducible
serine protease and chaperone HtrA was highly enriched in stress samples (fc of 2.6 and 2.0, 1h and
2h after stress, respectively) and the bacterial metabolism was clearly affected by LL-37, illustrated
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especially by higher amounts of MalP, MalQ and lower amounts of MalX. While proteins involved
in cell surface modification (DltD, LicD1, TacF, SrtA) showed significantly higher abundance under
stress, particularly after 2 h of stress, several virulence factors with a role in adhesion (histidine triad
proteins A, B and E) were less abundant upon stress with LL-37. Furthermore, proteins involved
in correct protein-folding (foldase PrsA) and biosynthesis (SsrA-binding protein SmpB) were more
abundant, and proteins involved in cell redox homeostasis (Tpx) and cell division (SepF, DivIVA) were
less abundant after LL-37 exposure. Lastly, the unknown proteins SPD_0913 (accumulated up to a fc of
2.8) and SPD_1515-17 (decreased clearly after 2 h of stress) changed significantly.
Based on the significant changes seen in the proteomic data, two mutants were chosen and
subjected to LL-37 sensitivity testing to support the putative role of the corresponding proteins in
LL-37 adaptation (Figure 7). This was done by stressing pneumococci and comparing the reduced
optical density of the stressed cells with the ones from the control condition. First, the sensitivity of the
S. pneumoniae D39∆dltD mutant towards LL-37 was evaluated, as DltD is known to effect resistance
to AMPs in pneumococci [46] and was also found to be more abundant in our dataset after LL-37
treatment. Additionally, S. pneumoniae D39∆licD2 was selected because LicD2 showed a similar change
in abundance after LL-37 stress to the significantly increased genomic neighbor LicD1 (without passing
the strict statistical parameters). Moreover, a deficiency in licD1 appears to be lethal [47]. As shown in
Figure 7, the growth of the wildtype D39 strain is reduced by about 21% after peptide stress compared
to the control condition, whereas growth of ∆dltD and ∆licD2 mutants are significantly reduced by
about 28% and 29% in comparison to the untreated strains, respectively.
Microorganisms 2020, 8, x FOR PEER REVIEW 10 of 15 
 
SrtA) showed significantly higher abundance under stress, particularly after 2 h of stress, several 
virulence factors with a role in adhesion (histidine triad proteins A, B and E) were less abundant 
upon stress with LL-37. Furthermore, proteins involved in correct protein-folding (foldase PrsA) and 
biosynthesis (SsrA-binding protein SmpB) were more abundant, and proteins involved in cell redox 
homeostasis (Tpx) and cell division (SepF, DivIVA) were less abundant after LL-37 exposure. Lastly, 
the unknown proteins SPD_0913 (accumulated up to a fc of 2.8) and SPD_1515-17 (decreased clearly 
after 2 h of stress) changed significantly. 
Based on the significant changes seen in the proteomic data, two mutants were chosen and 
subjected to LL-37 sensitivity testing to support the putative role of the corresponding proteins in LL-
37 adaptation (Figure 7). This was done by stressing pneumococci and comparing the reduced optical 
density of the stressed cells with the ones from the control condition. First, the sensitivity of the S. 
pneumoniae D39ΔdltD mutant towards LL-37 was evaluated, as DltD is known to effect resistance to 
AMPs in pneumococci [46] and was also found to be more abundant in our dataset after LL-37 
treatment. Additionally, S. pneumoniae D39ΔlicD2 was selected because LicD2 showed a similar 
change in abundance after LL-37 stress to the significantly increased genomic neighbor LicD1 
(without passing the strict statistical parameters). Moreover, a deficiency in licD1 appears to be lethal 
[47]. As shown in Figure 7, the growth of the wildtype D39 strain is reduced by about 21% after 
peptide stress compared to the control condition, whereas growth of ΔdltD and ΔlicD2 mutants are 
significantly reduced by about 28% and 29% in comparison to the untreated strains, respectively. 
 
Figure 7. Effect of 2.5 µg/mL LL-37 on the growth of S. pneumoniae D39 wildtype (wt) in comparison 
to stressed D39ΔdltD and D39ΔlicD2 mutants. The red arrow indicates the application of the stress 
after two hours of cultivation. The numbers represent the growth inhibition of stressed pneumococci 
compared to corresponding untreated D39 strains in percentage. * Significant difference between 
mutant and wt inhibition using one-tailed t-tests assuming unequal variance, p < 0.05. The error bars 
represent the standard deviation. n = 3. 
4. Discussion 
The presented dataset shows the highest proteome coverage for the S. pneumoniae D39 wildtype 
known to us. Furthermore, 105 proteins could be identified as significantly changed after LL-37 stress, 
while stressed bacteria showed a similar but about 20% reduced growth compared to unstressed cells. 
A total of 52 protein candidates with a potential specific function in LL-37 adaptation could be 
identified after comparison with transcriptomic and genomic data. 
Among these candidates are the teichoic acid flippase TacF (SPD_1128) [48] and LicD1 
(SPD_1129), an enzyme responsible for transfer of phosphorylcholine to teichoic acids, thereby 
mimicking eukaryotic membranes, increasing the surface charge and adding binding sites for choline 
binding proteins to the cell wall [24,49]. Interestingly, both corresponding RNA levels [45] and the 
Figure 7. Effect of 2.5 µg/mL LL-37 on the growth of S. pneumoniae D39 wildtype (wt) in comparison
to stressed D39∆dltD and D39∆licD2 mutants. The red arrow indicates the application of the stress
after two hours of cultivation. The numbers represent the growth inhibition of stressed pneumococci
compared to corresponding untreated D39 strains in percentage. * Significant difference between
mutant and wt inhibition using one-tailed t-tests assuming unequal variance, p < 0.05. The error bars
represent the standard deviation. n = 3.
4. Discussion
The presented dataset shows the highest proteome coverage for the S. pneumoniae D39 wildtype
known to us. Furthermore, 105 proteins could be identified as significantly changed after LL-37 stress,
while stressed bacteria showed a similar but about 20% reduced growth compared to unstressed
cells. A total of 52 protein candidates with a potential specific function in LL-37 adaptation could be
identified after comparison with transcriptomic and genomic data.
Among these candidates are the teichoic acid flippase TacF (SPD_1128) [48] and LicD1 (SPD_1129),
an enzyme responsible for transfer of phosphorylcholine to teichoic acids, thereby mimicking eukaryotic
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membranes, increasing the surface charge and adding binding sites for choline binding proteins to the
cell wall [24,49]. Interestingly, both corresponding RNA levels [45] and the protein abundance after 1 h
of stress are not significantly affected, but TacF and LicD1 proteins are significantly more abundant after
2 h of stress, suggesting a relatively slow regulation of protein level. Additionally, DltD (SPD_2002),
which alanylates teichoic acids and hence introduces positive charges to the cell surface [46], was more
abundant in stressed bacteria (after 1 and 2 h) in accordance with the accumulation of its RNA in the
transcriptomic dataset [45]. Next, the enzyme sortase SrtA is more abundant under 1 and 2 h of stress,
attaching LPXTG-motif proteins to the cell surface. Taking all that into account, it seems plausible
that pneumococci are also able to repel the positively charged LL-37 by cell wall adaptations. In fact,
a reduction in negative surface charge would decrease the electrostatical forces between the cationic
peptide (charge +6) and the bacteria, and thus decrease its antimicrobial effects. This appears even
more likely when considering that involvement of the dlt- and lic-operons in resistance to LL-37 in
other bacteria or of S. pneumoniae against other cationic antimicrobial peptides was already described.
In fact, non-functional dlt affected the resistance of S. pneumoniae to the bacterial secreted lantibiotics
nisin and gallidermin [46], and a lic mutation the susceptibility of Haemophilus influenzae towards
LL-37 [24]. Alternatively, LTA release, aiming for targeted binding of LL-37, would be an effective
interception mechanism against the action of the peptide [27], but was not examined in this study.
Furthermore, the abundance of several transporters, especially of the ABC type, was changed
in response to LL-37. Consistently using the annotation from TransportDB 2.0, the proteins with
transporter function appear to be enriched among the significantly changed proteins (23 out of 105;
22%), as there are 304 transporters annotated for the pneumococcal proteome (16%). The same trend
can be observed comparing the number of significantly changed transporters with the transporters
identified in our experiment (194 among 1293; 15%). These changes could lead to the removal of
LL-37 from the bacterial membrane, as shown for other bacteria and other cationic antimicrobial
peptides [50–52]. Interestingly, the accumulated transporter proteins are mainly regulated by GntR
(SPD_0686-88, SPD_1525-26) and the depleted ones by ComE (SPD_0374, SPD_1527-28), regulators
that are both more abundant after the addition of LL-37. The observation that many of the transporters
increased after stress, including the ones independent of GntR, has also been made on the RNA
level [45].
Besides that, the serine protease and chaperone HtrA (SPD_2068) is highly enriched in stress
samples. This finding could be explained by a potential LL-37-degrading function of the enzyme,
an enhanced removal of damaged or misfolded proteins in response to cell wall stress, or the role of
HtrA in competence (ComC degradation) and bacteriocin (BlpC degradation) regulation [53].
Then, the amount of proteins encoded by the maltose operon (MalP, MalQ) probably changed
due to changes in CiaR amounts. However, how this observation is connected to AMP adaptation is
still unclear.
Interestingly, three surface virulence proteins, the histidine triad protein A, B and E, are depleted
during stress, supposedly to reduce interaction with the immune system [54]. As the virulence proteins
are regulated by the Zn2+-dependent regulator AdcR, it was unexpected that AdcR did not change
significantly. However, posttranslational modifications or ligand-binding could alter the regulator’s
activity. Probably for the same reason, LytA was not found to be enriched even when the involvement
of this enzyme in LL-37 resistance was described for pneumococci [16]. In fact, LytA activation is
regulated by phosphorylation [55], and this could also be the case in this study.
Other proteins found to be regulated are foldase PrsA (accumulated at both sample points but
expression was not significantly affected) and several proteins involved in cell redox homeostasis,
e.g., the thioredoxin peroxidase Tpx (SPD_1464) (shows the same trend on RNA level [45]), and cell
division (SepF, DivIVA) (all three proteins are depleted). As foldases are chaperones and support
correct protein folding, presumably there is an enhanced accumulation of misfolded proteins after
LL-37 stress in pneumococci. Furthermore, virulence factors seem to be reduced after LL-37 stress
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(depletion of histidine triad proteins) and a hypothetical decreased production rate of host-damaging
H2O2 would explain the reduced synthesis of redox homeostasis proteins in pneumococci.
On the other hand, the regulation of pneumococcal adaptation in response to LL-37 seems to be
mainly mediated by the transcriptional regulator GntR (SPD_1524) and the two-component systems,
TCS05 CiaHR, TCS12 ComDE and TCS13 BlpHR (BlpS). In detail, GntR shows a substantial fold change
at both timepoints, and corresponding RNA was also found to be considerably more abundant [45].
Next, both components of the CiaHR system, the sensor histidine kinase CiaH and the response
regulator CiaR, are more abundant under stress on proteome and transcriptome level [45]. Finally,
the response regulator part of ComDE (ComE) was increased on the protein level and the BlpHR
two-component system was indirectly affected by an increase in BlpS protein and RNA in pneumococci
after LL-37 stress. Indeed, this makes sense considering the complex interaction of Cia, Com and Blp
regulatory systems [53], including the CiaHR-regulated degradation in ComC and BlpC signaling
peptides by HtrA. After focusing on targets of the CiaHR regulon (probably activated by surface
stress) [53] it becomes clear that it shows many of the effects known to be induced by its activity [43],
among them, the accumulation of serine protease HtrA, foldase PrsA, the metabolic proteins MalP and
MalQ and the unknown function protein SPD_0913.
Lastly, the data indicate that the unknown proteins SPD_0913, that was similarly induced on RNA
level [45], and SPD_1515-17 (identified as less abundant uniquely on proteome level), play a potential
role in innate immunity resistance. Perhaps SPD_1515-17 sensitizes pneumococci toward LL-37,
and therefore a decreased abundance of this protein, and other proteins reduced in abundance
after LL-37 stress, would result in a higher tolerance to the peptide. Backing up this hypothesis,
SPD_1515-16 are annotated as membrane proteins, being potentially in contact with membrane-acting
LL-37. However, the structures of these proteins are unknown, so that no statement can be made
regarding a potential negative surface charge of this protein that would attract cationic AMPs.
For the two proteins DltD and LicD2, the genomic neighbor of significantly regulated LicD1,
the role in LL-37 resistance was further supported by testing the sensitivity of D39 ∆dltD and ∆licD2
deletion mutants towards the peptide. As expected from the literature [46], the ∆dltD strain was more
susceptible to LL-37. Interestingly, the growth of the stressed ∆licD2 mutant was even more reduced,
indicating a role of the phosphorylcholine transferases LicD1-2 in LL-37 resistance, potentially by
modifying the bacterial surface charge [24].
In conclusion, our study suggests that pneumococci may use adaptation mechanisms repulsion,
export, and potentially degradation and interception to reduce the effects of the antimicrobial peptide
LL-37. Certainly, this has yet to be confirmed in follow up experiments. However, as many of the
presented candidates are changed at transcriptome and proteome levels in pneumococci, and several
sequence similar proteins were already linked to AMP resistance in other bacteria, the presented
candidates should be considered as highly relevant drug targets.
Finally, global knowledge about bacterial resistance mechanisms to AMPs could be used to
design new drugs, blocking the functional players of resistance. These components would sensitize
pathogens to already existing AMPs in the human body. In fact, it was already shown that inhibition
of the dlt operon, normally reducing the bacterial membrane charge by modifying teichoic acids with
D-alanine, sensitizes Gram-positive B. subtilis to cell-wall acting-antibiotics [56]. Other targets for
this approach could be the teichoic acid flippase TacF (SPD_1128), the phosphorylcholine transferases
LicD1-2 or stress-induced efflux pumps that potentially export AMPs out of the bacteria. However,
further research is needed to verify the role of AMP resistance candidates discussed here and design
appropriate inhibitor molecules.
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